Antisense Oligonucleotide Therapeutics Targeting Age-Related Diseases. [PDF]
Lee HG, Kim J, Jang CY, Shin M.
europepmc +1 more source
Antisense Oligonucleotide-Mediated <i>XIST</i> Knockdown Modulates Endogenous Pluripotency-Associated Transcription Factor Expression in Porcine Female Somatic Cells. [PDF]
Chen X +7 more
europepmc +1 more source
Pharmacological targeting of SF3a1-MDM4 splicing vulnerability in ovarian cancer with rifaximin and antisense oligonucleotide. [PDF]
Shuai X +5 more
europepmc +1 more source
Deep learning facilitates efficient optimization of antisense oligonucleotide drugs
Shenggeng Lin +3 more
doaj +1 more source
Antisense oligonucleotide selection scheme for rare Duchenne muscular dystrophy mutations: Application to <i>DMD</i> exon 16 skipping. [PDF]
Geoffroy-Guiraud M +8 more
europepmc +1 more source
Antisense oligonucleotide allele-specific targeting of EFEMP1 in a patient-derived model of Doyne honeycomb retinal dystrophy. [PDF]
Rezek FO +10 more
europepmc +1 more source
Antisense oligonucleotide-mediated knockdown therapy in two infants with severe KCNT1 epileptic encephalopathy. [PDF]
Nakayama T +34 more
europepmc +1 more source
Correction to 'Integrating transcriptomics and proteomics to assess antisense oligonucleotide safety and efficacy: a time-resolved approach'. [PDF]
europepmc +1 more source
Antisense oligonucleotide therapies for monogenic disorders. [PDF]
Krey-Grauert I, Ferro I, Wagner M.
europepmc +1 more source

